Argenx Se (ARGX) Current Leases (2019 - 2025)

Argenx Se (ARGX) posted Current Leases of $10.8 million for Q4 2025, down 99.97% on a QoQ basis from $35.6 billion in Q2 2025, and up 65.82% year-over-year from $6.5 million in Q4 2024.

Argenx Se (ARGX) Current Leases (2019 - 2025) Analysis & Trends

Argenx Se's Current Leases history runs 7 years deep, the most recent figure standing at $10.8 million for Q4 2025.

  • Quarterly Current Leases rose 65.82% year-over-year to $10.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.8 million (up 65.82% YoY) and the FY2025 annual result came in at $10.8 million, up 65.82% from the prior year.
  • Current Leases was $10.8 million for Q4 2025 at Argenx Se, down from $35.6 billion in the prior quarter.
  • Across five years, Current Leases topped out at $35.6 billion in Q2 2025 and bottomed at $3.4 million in Q4 2022.
  • A 5-year average of $3.6 billion and a median of $6.4 million in 2022 frame the typical range for Current Leases.
  • Annual changes were most pronounced in 2022 — Current Leases declined 2.62% — and 2025, when it soared 126444.99%.
  • Argenx Se's Current Leases stood at $3.5 million in 2021, then dropped by 2.62% to $3.4 million in 2022, then jumped by 35.97% to $4.6 million in 2023, then surged by 40.62% to $6.5 million in 2024, then soared by 65.82% to $10.8 million in 2025.
  • Business Quant data shows ARGX's Current Leases at $10.8 million in Q4 2025, $35.6 billion in Q2 2025, and $6.5 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 531,233.95
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 20.58 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 720.00 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 16.61 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 45.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 10.83 Mn
Jun 30, 2025 35.57 Bn
Dec 31, 2024 6.53 Mn
Jun 30, 2024 28.11 Mn
Dec 31, 2023 4.65 Mn
Jun 30, 2023 8.04 Mn
Dec 31, 2022 3.42 Mn
Jun 30, 2022 6.21 Mn
Dec 31, 2021 3.51 Mn
Jun 30, 2021 3.45 Mn
Dec 31, 2020 3.38 Mn
Jun 30, 2020 2.48 Mn
Dec 31, 2019 2.18 Mn
Jun 30, 2019 1.21 Mn